Invention Grant
US07973138B2 Antibodies 有权
抗体

Antibodies
Abstract:
The present invention relates to the use of VEGF antagonists and a novel anti-α5β1 antibody for treating cancer and inhibiting angiogenesis and/or vascular permability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to compositions and kits comprising novel anti-α5β1 antibodies and methods of making and using them.
Public/Granted literature
Information query
Patent Agency Ranking
0/0